DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
Medical Device Network on MSN3d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
MedTech Dive4d
Dexcom receives warning letter based on FDA inspections of 2 plants
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Nasdaq28d
DexCom Unusual Options Activity
Financial giants have made a conspicuous bearish move on DexCom. Our analysis of options history for DexCom (NASDAQ:DXCM) revealed 12 unusual trades. Delving into the details, we found 33% of ...
Hosted on MSN28d
DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins
DexCom, Inc. DXCM reported fourth-quarter 2024 ... The broader S&P 500 Index has moved up 10% in the same period. Image Source: Zacks Investment Research Sensor and other revenues (96% of total ...